Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 2
1987 4
1988 2
1989 2
1991 1
1992 7
1993 2
1994 3
1995 1
2001 1
2002 3
2004 3
2005 2
2006 3
2007 4
2008 4
2009 4
2010 5
2011 4
2012 1
2013 1
2014 1
2015 2
2016 2
2017 1
2019 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

65 results

Results by year

Filters applied: . Clear all
Page 1
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JF, Nauck MA, Nissen SE, Pocock S, Poulter NR, Ravn LS, Steinberg WM, Stockner M, Zinman B, Bergenstal RM, Buse JB; LEADER Steering Committee; LEADER Trial Investigators. Marso SP, et al. N Engl J Med. 2016 Jul 28;375(4):311-22. doi: 10.1056/NEJMoa1603827. Epub 2016 Jun 13. N Engl J Med. 2016. PMID: 27295427 Free PMC article. Clinical Trial.
Liraglutide and Renal Outcomes in Type 2 Diabetes.
Mann JFE, Ørsted DD, Brown-Frandsen K, Marso SP, Poulter NR, Rasmussen S, Tornøe K, Zinman B, Buse JB; LEADER Steering Committee and Investigators. Mann JFE, et al. N Engl J Med. 2017 Aug 31;377(9):839-848. doi: 10.1056/NEJMoa1616011. N Engl J Med. 2017. PMID: 28854085 Free article. Clinical Trial.
Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial.
Dormandy JA, Charbonnel B, Eckland DJ, Erdmann E, Massi-Benedetti M, Moules IK, Skene AM, Tan MH, Lefèbvre PJ, Murray GD, Standl E, Wilcox RG, Wilhelmsen L, Betteridge J, Birkeland K, Golay A, Heine RJ, Korányi L, Laakso M, Mokán M, Norkus A, Pirags V, Podar T, Scheen A, Scherbaum W, Schernthaner G, Schmitz O, Skrha J, Smith U, Taton J; PROactive Investigators. Dormandy JA, et al. Lancet. 2005 Oct 8;366(9493):1279-89. doi: 10.1016/S0140-6736(05)67528-9. Lancet. 2005. PMID: 16214598 Free article. Clinical Trial.
[Hypothyroidism and serum enzyme].
Møller-Petersen J, Andersen PT, Lervang HH. Møller-Petersen J, et al. Among authors: lervang hh. Ugeskr Laeger. 1988 Aug 22;150(34):2019-22. Ugeskr Laeger. 1988. PMID: 2457972 Danish. No abstract available.
[Type 2 diabetes--new treatment].
Lervang HH. Lervang HH. Ugeskr Laeger. 2001 Oct 29;163(44):6101. Ugeskr Laeger. 2001. PMID: 11715150 Danish. No abstract available.
Methylprednisolone pulse therapy in severe acute asthma.
Pedersen BK, Laursen LC, Lervang HH, Stjernebjerg T, Weeke B. Pedersen BK, et al. Among authors: lervang hh. Allergy. 1987 Feb;42(2):154-7. doi: 10.1111/j.1398-9995.1987.tb02375.x. Allergy. 1987. PMID: 3296841 Clinical Trial.
The effect of n-3 polyunsaturated fatty acids on Lp(a).
Schmidt EB, Klausen IC, Kristensen SD, Lervang HH, Faergeman O, Dyerberg J. Schmidt EB, et al. Among authors: lervang hh. Clin Chim Acta. 1991 May 15;198(3):271-7. doi: 10.1016/0009-8981(91)90362-g. Clin Chim Acta. 1991. PMID: 1832343 No abstract available.
65 results